Kurs
+1,57%
Kurs
+1,57%
Open
51,20
High
53,20
Low
50,60
Close
51,80
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
2,36 MNOK
Likviditet
2,36 MNOK
Rel. mcap
0,54%
Antal aktier
45 600
Likviditet under dagen för detta pressmeddelande
Kalender
Tid* | ||
2026-02-12 | 07:30 | Bokslutskommuniké 2025 |
2025-11-06 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-08-21 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-05-08 | 07:00 | Kvartalsrapport 2025-Q1 |
2025-04-24 | N/A | X-dag ordinarie utdelning ULTI 0.00 NOK |
2025-04-23 | N/A | Årsstämma |
2025-01-31 | - | Bokslutskommuniké 2024 |
2025-01-09 | - | Extra Bolagsstämma 2025 |
2024-11-06 | - | Kvartalsrapport 2024-Q3 |
2024-08-21 | - | Kvartalsrapport 2024-Q2 |
2024-05-07 | - | Kvartalsrapport 2024-Q1 |
2024-04-25 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2024-04-24 | - | Årsstämma |
2024-02-14 | - | Bokslutskommuniké 2023 |
2023-11-08 | - | Kvartalsrapport 2023-Q3 |
2023-08-22 | - | Kvartalsrapport 2023-Q2 |
2023-05-10 | - | Kvartalsrapport 2023-Q1 |
2023-04-21 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2023-04-20 | - | Årsstämma |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-11-10 | - | Kvartalsrapport 2022-Q3 |
2022-08-19 | - | Kvartalsrapport 2022-Q2 |
2022-05-12 | - | Kvartalsrapport 2022-Q1 |
2022-04-21 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2022-04-20 | - | Årsstämma |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-11-11 | - | Kvartalsrapport 2021-Q3 |
2021-08-20 | - | Kvartalsrapport 2021-Q2 |
2021-05-11 | - | Kvartalsrapport 2021-Q1 |
2021-04-22 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2021-04-21 | - | Årsstämma |
2021-02-17 | - | Bokslutskommuniké 2020 |
2020-11-12 | - | Kvartalsrapport 2020-Q3 |
2020-11-11 | - | Extra Bolagsstämma 2020 |
2020-08-21 | - | Kvartalsrapport 2020-Q2 |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-04-16 | - | X-dag ordinarie utdelning ULTI 0.00 NOK |
2020-04-15 | - | Årsstämma |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-11-14 | - | Kvartalsrapport 2019-Q3 |
2019-08-21 | - | Kvartalsrapport 2019-Q2 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2020-11-09 10:30:37
Oslo, 9 November 2020: Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), a
pharmaceutical company developing novel immunotherapies against cancer, invites
to a webcast presentation of its third quarter 2020 results on Thursday 12
November 2020.
The presentation can be followed as a live webcast (access through link
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201112_4) at 09:00
CET on Thursday 12 November 2020. The webcast presentation will be available on
our website, and it will be possible to post questions during the presentation
through the webcast.
The report and presentation will be available on the company website from 08:00
CET the same day.
For further information, please visit www.ultimovacs.com or contact:
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632